This was also investigated in IMR-32 cells (Supplementary Figure 4) that confirmed the up-regulation of S100A6; IP3R3 and RYR3 but showed no down-regulation of RYR1 in CDDP treated neuroblastoma cells (Supplementary Figure 4). This evidence concerns the gene RYR3 and neuroblastoma.